Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Oncogene
|
February 15, 1996
The human tumour suppressor gene p53 is alternatively spliced in normal cells
J M Flaman, F Waridel, A Estreicher, et al.
Japanese Journal of Cancer Research : Gann
|
September 17, 1998
Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma
H Fujimoto, J Sasaki, M Matsumoto, et al.
Gene Therapy
|
October 26, 2007
SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene
A Merron, I Peerlinck, P Martin-Duque, et al.
Oncogene
|
June 29, 2001
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements
P Campomenosi, P Monti, A Aprile, et al.
Oncology
|
March 13, 2001
Evaluation of methods to detect p53 mutations in ovarian cancer
I Meinhold-Heerlein, E Ninci, H Ikenberg, et al.
The American Journal of Pathology
|
October 1, 1996
Germ cell tumors of the testis overexpress wild-type p53
L Guillou, A Estreicher, P Chaubert, et al.
Human Gene Therapy
|
August 20, 2008
Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus
M Bazan-Peregrino, R C Carlisle, R Hernandez-Alcoceba, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 13, 2023
Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis
C Gounou, L Rouyer, G Siegfried, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Oncogene
|
February 15, 1996
The human tumour suppressor gene p53 is alternatively spliced in normal cells
J M Flaman, F Waridel, A Estreicher, et al.
Japanese Journal of Cancer Research : Gann
|
September 17, 1998
Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma
H Fujimoto, J Sasaki, M Matsumoto, et al.
Gene Therapy
|
October 26, 2007
SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene
A Merron, I Peerlinck, P Martin-Duque, et al.
Oncogene
|
June 29, 2001
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements
P Campomenosi, P Monti, A Aprile, et al.
Oncology
|
March 13, 2001
Evaluation of methods to detect p53 mutations in ovarian cancer
I Meinhold-Heerlein, E Ninci, H Ikenberg, et al.
The American Journal of Pathology
|
October 1, 1996
Germ cell tumors of the testis overexpress wild-type p53
L Guillou, A Estreicher, P Chaubert, et al.
Human Gene Therapy
|
August 20, 2008
Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus
M Bazan-Peregrino, R C Carlisle, R Hernandez-Alcoceba, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 13, 2023
Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis
C Gounou, L Rouyer, G Siegfried, et al.
Page
of 4